Omacor effects on serum lipids and clinical outcome.
Ito
Matthew K
MK
Marrs
Joel
J
Williams
Craig
C
D004281:Docosahexaenoic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000188:drug therapy*; D014280:Triglycerides / Q000097:blood*
D004338:Drug Combinations; D015525:Fatty Acids, Omega-3; D014280:Triglycerides; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid; C405603:Omacor